Terumo Of Japan Expands Presence in South Africa
This article was originally published in PharmAsia News
Japanese medical device maker Terumo expands its operations in South Africa. Since the company established an office in Johannesburg in October 2007, the staff has increased from six to eight to accommodate a higher demand for cardiovascular and circulation products such as pump oxygenators. The company plans to further expand to nine staff next year. Starting this year, Terumo also obtained a license and started training local physicians, aiming to expand its catheters in the country. The company is also considering introducing syringes with safety functions to the market as South Africa has a high rate of infection caused by injection needles. (Click here for more - Japanese language
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.